These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 28483801)

  • 41. Fatty acid-induced defects in insulin signalling, in myotubes derived from children, are related to ceramide production from palmitate rather than the accumulation of intramyocellular lipid.
    Sabin MA; Stewart CE; Crowne EC; Turner SJ; Hunt LP; Welsh GI; Grohmann MJ; Holly JM; Shield JP
    J Cell Physiol; 2007 Apr; 211(1):244-52. PubMed ID: 17219404
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Palmitate-induced PTP1B expression is mediated by ceramide-JNK and nuclear factor κB (NF-κB) activation.
    MohammadTaghvaei N; Taheripak G; Taghikhani M; Meshkani R
    Cell Signal; 2012 Oct; 24(10):1964-70. PubMed ID: 22580159
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma Amino Acids Stimulate Uncoupled Respiration of Muscle Subsarcolemmal Mitochondria in Lean but Not Obese Humans.
    Kras KA; Hoffman N; Roust LR; Patel SH; Carroll CC; Katsanos CS
    J Clin Endocrinol Metab; 2017 Dec; 102(12):4515-4525. PubMed ID: 29029131
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Short-term manipulation of plasma free fatty acids does not change skeletal muscle concentrations of ceramide and glucosylceramide in lean and overweight subjects.
    Serlie MJ; Meijer AJ; Groener JE; Duran M; Endert E; Fliers E; Aerts JM; Sauerwein HP
    J Clin Endocrinol Metab; 2007 Apr; 92(4):1524-9. PubMed ID: 17264178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of metformin on bioactive lipid metabolism in insulin-resistant muscle.
    Zabielski P; Chacinska M; Charkiewicz K; Baranowski M; Gorski J; Blachnio-Zabielska AU
    J Endocrinol; 2017 Jun; 233(3):329-340. PubMed ID: 28522731
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased Serum Levels of Sphingomyelins and Ceramides in Sickle Cell Disease Patients.
    Aslan M; Kıraç E; Kaya S; Özcan F; Salim O; Küpesiz OA
    Lipids; 2018 Mar; 53(3):313-322. PubMed ID: 29663386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduced cardiovascular risk after bariatric surgery is linked to plasma ceramides, apolipoprotein-B100, and ApoB100/A1 ratio.
    Heneghan HM; Huang H; Kashyap SR; Gornik HL; McCullough AJ; Schauer PR; Brethauer SA; Kirwan JP; Kasumov T
    Surg Obes Relat Dis; 2013; 9(1):100-7. PubMed ID: 22264909
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ceramide mediates inhibition of the AKT/eNOS signaling pathway by palmitate in human vascular endothelial cells.
    Xiao-Yun X; Zhuo-Xiong C; Min-Xiang L; Xingxuan H; Schuchman EH; Feng L; Han-Song X; An-Hua L
    Med Sci Monit; 2009 Sep; 15(9):BR254-61. PubMed ID: 19721393
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oleate dose-dependently regulates palmitate metabolism and insulin signaling in C2C12 myotubes.
    Capel F; Cheraiti N; Acquaviva C; Hénique C; Bertrand-Michel J; Vianey-Saban C; Prip-Buus C; Morio B
    Biochim Biophys Acta; 2016 Dec; 1861(12 Pt A):2000-2010. PubMed ID: 27725263
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diabetes mellitus is associated with increased intramyocellular triglyceride, but not diglyceride, content in obese humans.
    Anastasiou CA; Kavouras SA; Lentzas Y; Gova A; Sidossis LS; Melidonis A
    Metabolism; 2009 Nov; 58(11):1636-42. PubMed ID: 19615699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Skeletal muscle triglycerides, diacylglycerols, and ceramides in insulin resistance: another paradox in endurance-trained athletes?
    Amati F; Dubé JJ; Alvarez-Carnero E; Edreira MM; Chomentowski P; Coen PM; Switzer GE; Bickel PE; Stefanovic-Racic M; Toledo FG; Goodpaster BH
    Diabetes; 2011 Oct; 60(10):2588-97. PubMed ID: 21873552
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Muscle type dependent increase in intramyocellular lipids during prolonged fasting of human subjects: a proton MRS study.
    Wietek BM; Machann J; Mader I; Thamer C; Häring HU; Claussen CD; Stumvoll M; Schick F
    Horm Metab Res; 2004 Sep; 36(9):639-44. PubMed ID: 15486816
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sphingolipid Metabolism: New Insight into Ceramide-Induced Lipotoxicity in Muscle Cells.
    Bandet CL; Tan-Chen S; Bourron O; Le Stunff H; Hajduch E
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678043
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ceramide synthase 4 and de novo production of ceramides with specific N-acyl chain lengths are involved in glucolipotoxicity-induced apoptosis of INS-1 β-cells.
    Véret J; Coant N; Berdyshev EV; Skobeleva A; Therville N; Bailbé D; Gorshkova I; Natarajan V; Portha B; Le Stunff H
    Biochem J; 2011 Aug; 438(1):177-89. PubMed ID: 21592087
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intracellular localization of diacylglycerols and sphingolipids influences insulin sensitivity and mitochondrial function in human skeletal muscle.
    Perreault L; Newsom SA; Strauss A; Kerege A; Kahn DE; Harrison KA; Snell-Bergeon JK; Nemkov T; D'Alessandro A; Jackman MR; MacLean PS; Bergman BC
    JCI Insight; 2018 Feb; 3(3):. PubMed ID: 29415895
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CrossTalk opposing view: Intramyocellular ceramide accumulation does not modulate insulin resistance.
    Petersen MC; Jurczak MJ
    J Physiol; 2016 Jun; 594(12):3171-4. PubMed ID: 26997581
    [No Abstract]   [Full Text] [Related]  

  • 57. Modulating serine palmitoyl transferase (SPT) expression and activity unveils a crucial role in lipid-induced insulin resistance in rat skeletal muscle cells.
    Watson ML; Coghlan M; Hundal HS
    Biochem J; 2009 Feb; 417(3):791-801. PubMed ID: 18922131
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of de novo ceramide synthesis reverses diet-induced insulin resistance and enhances whole-body oxygen consumption.
    Ussher JR; Koves TR; Cadete VJ; Zhang L; Jaswal JS; Swyrd SJ; Lopaschuk DG; Proctor SD; Keung W; Muoio DM; Lopaschuk GD
    Diabetes; 2010 Oct; 59(10):2453-64. PubMed ID: 20522596
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma C18:0-ceramide is a novel potential biomarker for disease severity in myasthenia gravis.
    Zhang Z; Huang X; Du X; Wang Z; Wang Y; Xu M; Chen X; Yao Q; Yan L; Zhang Y
    J Neurochem; 2023 Jun; 165(6):907-919. PubMed ID: 37158660
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between Plasmatic Ceramides Profile and AST/ALT Ratio: C14:0 Ceramide as Predictor of Hepatic Steatosis in Adolescents Independently of Obesity.
    Maldonado-Hernández J; Saldaña-Dávila GE; Piña-Aguero MI; Núñez-García BA; López-Alarcón MG
    Can J Gastroenterol Hepatol; 2017; 2017():3689375. PubMed ID: 28634575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.